Useful aspects of submitted secondary pharmacology data. Detailed aspects of secondary pharmacology data that are considered to be useful during regulatory safety assessments are summarized in Table 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback